Sign in
4

Changes in Ownership

Kura Oncology, Inc. Filed Acc 0001193125-26-025302

SVP, Finance & Accounting sold 7,142 shares at $8.46 ($60,426)

From the SEC's structured data for this filing

Trades in this filing

DOYLE THOMAS JAMES · SVP, Finance & Accounting

Table I: Non-derivative

5 lines
Date Transaction Shares Price Value Owned after D/I
2026-01-27 Sale : show line 1 in the form −2,226 $8.46 $18,834 150,083 D
2026-01-27 Sale : show line 2 in the form −1,114 $8.46 $9,425 148,969 D
2026-01-27 Sale : show line 3 in the form −695 $8.46 $5,880 148,274 D
2026-01-27 Sale : show line 4 in the form −2,226 $8.46 $18,834 146,048 D
2026-01-27 Sale : show line 5 in the form −881 $8.46 $7,454 145,167 D
Open-market sales · 7,142 sh · avg $8.46 · $60,426
Loading xslF345X05/ownership.xml…